1. Home
  2. CRBU vs TAYD Comparison

CRBU vs TAYD Comparison

Compare CRBU & TAYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.82

Market Cap

166.6M

Sector

Health Care

ML Signal

HOLD

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$57.05

Market Cap

170.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
TAYD
Founded
2011
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
166.6M
170.7M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
CRBU
TAYD
Price
$1.82
$57.05
Analyst Decision
Strong Buy
Hold
Analyst Count
4
1
Target Price
$10.75
$70.00
AVG Volume (30 Days)
2.3M
39.7K
Earning Date
05-08-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
11.24
EPS
N/A
2.87
Revenue
N/A
$46,292,725.00
Revenue This Year
$1.63
$0.25
Revenue Next Year
$10.93
$19.78
P/E Ratio
N/A
$19.88
Revenue Growth
N/A
3.84
52 Week Low
$1.38
$40.50
52 Week High
$3.53
$90.37

Technical Indicators

Market Signals
Indicator
CRBU
TAYD
Relative Strength Index (RSI) 50.55 52.60
Support Level $1.70 $56.80
Resistance Level $2.02 $59.99
Average True Range (ATR) 0.12 2.74
MACD 0.02 0.16
Stochastic Oscillator 72.22 43.47

Price Performance

Historical Comparison
CRBU
TAYD

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

Share on Social Networks: